Insider Trading February 2, 2026

Lindblad Insider Sells $3.07M in Stock as Company Faces EPS Miss and Preferred Conversion

Director and 10% holder executed two Rule 10b5-1 sales; company posts revenue beat but flat EPS and prepares conversion of Series A preferred into common shares

By Nina Shah LIND
Lindblad Insider Sells $3.07M in Stock as Company Faces EPS Miss and Preferred Conversion
LIND

Lindblad Expeditions insider Sven-Olof sold 183,639 shares across two days for roughly $3.07 million under a Rule 10b5-1 plan. The disposals leave him with 11,172,779 shares. The transactions come after the company reported third-quarter 2025 revenue ahead of expectations but an earnings-per-share shortfall, and announced a mandatory conversion of its 6.0% Series A Convertible Preferred Stock into about 9.0 million common shares on February 3, 2026. Analysts have reiterated and raised price targets amid reported increased institutional interest.

Key Points

  • Insider Sven-Olof sold 183,639 shares under a Rule 10b5-1 plan on Jan. 29-30, 2026, for about $3.07 million.
  • Lindblad reported Q3 2025 revenue of $240.2 million, topping forecasts of $230.3 million, but posted EPS of $0.00 versus an expected $0.19.
  • All 6.0% Series A Convertible Preferred Stock will mandatorily convert into roughly 9.0 million common shares on Feb. 3, 2026; analysts from Benchmark and Stifel maintained or raised Buy ratings and price targets.

Director and 10% owner Sven-Olof executed a two-day disposal of Lindblad Expeditions Holdings Inc (NASDAQ:LIND) common stock on January 29 and January 30, 2026, selling a total of 183,639 shares for approximately $3.07 million.

The sales were carried out under a Rule 10b5-1 trading arrangement and comprised two separate transactions. On January 29, 105,356 shares were sold at a weighted average price of $16.8405 per share, with individual sale prices ranging from $16.50 to $17.05. On January 30, a further 78,283 shares changed hands at a weighted average price of $16.6594, with prices in that tranche spanning $16.42 to $16.82.

Following these dispositions, Sven-Olof retains direct ownership of 11,172,779 shares of Lindblad Expeditions Holdings common stock.


These insider transactions arrive amid recent corporate updates. Lindblad reported third-quarter 2025 revenue of $240.2 million, above analysts' consensus of $230.3 million. Despite the top-line beat, the company recorded earnings per share of $0.00, missing the $0.19 per-share estimate.

Further capital-structure activity is scheduled. The company has announced the mandatory conversion of all outstanding 6.0% Series A Convertible Preferred Stock into approximately 9.0 million shares of common stock, effective February 3, 2026. The conversion follows the company’s stock price having exceeded the required conversion threshold of $14.25 for an extended period.

On the analyst front, Benchmark reiterated its Buy rating on Lindblad Expeditions and kept an $18 price target, citing greater institutional interest. Separately, Stifel raised its price target on the company to $23 and maintained a Buy rating following conversations with Lindblad's leadership. The coverage and ratings activity also included Benchmark initiating coverage with a Buy rating that highlighted the company’s position in the high-end expedition travel sector.

Collectively, the insider selling, the quarterly results that combine a revenue beat with an EPS miss, and the upcoming preferred-stock conversion represent a sequence of developments investors will weigh as they assess Lindblad’s capital structure and near-term outlook.

Risks

  • The company missed consensus earnings per share for Q3 2025, reporting $0.00 against an expected $0.19 - a potential concern for profitability metrics.
  • Mandatory conversion of the 6.0% Series A Convertible Preferred Stock into approximately 9.0 million common shares on Feb. 3, 2026 introduces a known increase in outstanding common share count.
  • Insider sale of 183,639 shares over two days could add near-term selling pressure; the transactions were executed under a Rule 10b5-1 plan.

More from Insider Trading

Spyre Therapeutics CFO Disposes $370K in Stock, Exercises Options Same Day as Trial Timelines Accelerate Apr 3, 2026 Fold Holdings CEO completes modest stock sale to cover RSU tax obligations Apr 3, 2026 Spyre Therapeutics CEO Executes $739,912 Stock Sale as Trials Accelerate Apr 3, 2026 Spyre Therapeutics CMO Sells Shares, Exercises Options as Trials Accelerate Apr 3, 2026 Fold CFO Sells Small Stake to Meet Tax Withholding as Company Faces Revenue Shortfall Apr 3, 2026